Click for best price
Radiolig Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Radioligand Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioligand Therapy. This report contains market size and forecasts of Radioligand Therapy in global, including the following market information:
Global Radioligand Therapy Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Radioligand Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Actinium 225 (Ac-225) Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Radioligand Therapy include Novartis, Advanced Accelerator Applications, Mercy Radiology, POINT Biopharma Global Inc, Fusion Pharma, Telix Pharmaceuticals Ltd, Lantheus Holdings, Inc, Bayer AG and Curium Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioligand Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioligand Therapy Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Radioligand Therapy Market Segment Percentages, by Type, 2022 (%)
Actinium 225 (Ac-225)
Lutetium 177 (Lu-177)
Gallium 68 (Ga-68)
Fluorine 18 (F-18)
Other Radionuclides
Global Radioligand Therapy Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Radioligand Therapy Market Segment Percentages, by Application, 2022 (%)
Neuroendocrine Neoplasms
Prostate Cancer
Global Radioligand Therapy Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Radioligand Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioligand Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radioligand Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Advanced Accelerator Applications
Mercy Radiology
POINT Biopharma Global Inc
Fusion Pharma
Telix Pharmaceuticals Ltd
Lantheus Holdings, Inc
Bayer AG
Curium Pharma
Precirix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radioligand Therapy, market overview.
Chapter 2: Global Radioligand Therapy market size in revenue.
Chapter 3: Detailed analysis of Radioligand Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radioligand Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Radioligand Therapy Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radioligand Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioligand Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioligand Therapy Overall Market Size
2.1 Global Radioligand Therapy Market Size: 2022 VS 2035
2.2 Global Radioligand Therapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioligand Therapy Players in Global Market
3.2 Top Global Radioligand Therapy Companies Ranked by Revenue
3.3 Global Radioligand Therapy Revenue by Companies
3.4 Top 3 and Top 5 Radioligand Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radioligand Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioligand Therapy Players in Global Market
3.6.1 List of Global Tier 1 Radioligand Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioligand Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radioligand Therapy Market Size Markets, 2022 & 2035
4.1.2 Actinium 225 (Ac-225)
4.1.3 Lutetium 177 (Lu-177)
4.1.4 Gallium 68 (Ga-68)
4.1.5 Fluorine 18 (F-18)
4.1.6 Other Radionuclides
4.2 By Type - Global Radioligand Therapy Revenue & Forecasts
4.2.1 By Type - Global Radioligand Therapy Revenue, 2018-2023
4.2.2 By Type - Global Radioligand Therapy Revenue, 2024-2035
4.2.3 By Type - Global Radioligand Therapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioligand Therapy Market Size, 2022 & 2035
5.1.2 Neuroendocrine Neoplasms
5.1.3 Prostate Cancer
5.2 By Application - Global Radioligand Therapy Revenue & Forecasts
5.2.1 By Application - Global Radioligand Therapy Revenue, 2018-2023
5.2.2 By Application - Global Radioligand Therapy Revenue, 2024-2035
5.2.3 By Application - Global Radioligand Therapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Radioligand Therapy Market Size, 2022 & 2035
6.2 By Region - Global Radioligand Therapy Revenue & Forecasts
6.2.1 By Region - Global Radioligand Therapy Revenue, 2018-2023
6.2.2 By Region - Global Radioligand Therapy Revenue, 2024-2035
6.2.3 By Region - Global Radioligand Therapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Radioligand Therapy Revenue, 2018-2035
6.3.2 US Radioligand Therapy Market Size, 2018-2035
6.3.3 Canada Radioligand Therapy Market Size, 2018-2035
6.3.4 Mexico Radioligand Therapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Radioligand Therapy Revenue, 2018-2035
6.4.2 Germany Radioligand Therapy Market Size, 2018-2035
6.4.3 France Radioligand Therapy Market Size, 2018-2035
6.4.4 U.K. Radioligand Therapy Market Size, 2018-2035
6.4.5 Italy Radioligand Therapy Market Size, 2018-2035
6.4.6 Russia Radioligand Therapy Market Size, 2018-2035
6.4.7 Nordic Countries Radioligand Therapy Market Size, 2018-2035
6.4.8 Benelux Radioligand Therapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Radioligand Therapy Revenue, 2018-2035
6.5.2 China Radioligand Therapy Market Size, 2018-2035
6.5.3 Japan Radioligand Therapy Market Size, 2018-2035
6.5.4 South Korea Radioligand Therapy Market Size, 2018-2035
6.5.5 Southeast Asia Radioligand Therapy Market Size, 2018-2035
6.5.6 India Radioligand Therapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Radioligand Therapy Revenue, 2018-2035
6.6.2 Brazil Radioligand Therapy Market Size, 2018-2035
6.6.3 Argentina Radioligand Therapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioligand Therapy Revenue, 2018-2035
6.7.2 Turkey Radioligand Therapy Market Size, 2018-2035
6.7.3 Israel Radioligand Therapy Market Size, 2018-2035
6.7.4 Saudi Arabia Radioligand Therapy Market Size, 2018-2035
6.7.5 UAE Radioligand Therapy Market Size, 2018-2035
7 Radioligand Therapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Radioligand Therapy Major Product Offerings
7.1.4 Novartis Radioligand Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Advanced Accelerator Applications
7.2.1 Advanced Accelerator Applications Company Summary
7.2.2 Advanced Accelerator Applications Business Overview
7.2.3 Advanced Accelerator Applications Radioligand Therapy Major Product Offerings
7.2.4 Advanced Accelerator Applications Radioligand Therapy Revenue in Global Market (2018-2023)
7.2.5 Advanced Accelerator Applications Key News & Latest Developments
7.3 Mercy Radiology
7.3.1 Mercy Radiology Company Summary
7.3.2 Mercy Radiology Business Overview
7.3.3 Mercy Radiology Radioligand Therapy Major Product Offerings
7.3.4 Mercy Radiology Radioligand Therapy Revenue in Global Market (2018-2023)
7.3.5 Mercy Radiology Key News & Latest Developments
7.4 POINT Biopharma Global Inc
7.4.1 POINT Biopharma Global Inc Company Summary
7.4.2 POINT Biopharma Global Inc Business Overview
7.4.3 POINT Biopharma Global Inc Radioligand Therapy Major Product Offerings
7.4.4 POINT Biopharma Global Inc Radioligand Therapy Revenue in Global Market (2018-2023)
7.4.5 POINT Biopharma Global Inc Key News & Latest Developments
7.5 Fusion Pharma
7.5.1 Fusion Pharma Company Summary
7.5.2 Fusion Pharma Business Overview
7.5.3 Fusion Pharma Radioligand Therapy Major Product Offerings
7.5.4 Fusion Pharma Radioligand Therapy Revenue in Global Market (2018-2023)
7.5.5 Fusion Pharma Key News & Latest Developments
7.6 Telix Pharmaceuticals Ltd
7.6.1 Telix Pharmaceuticals Ltd Company Summary
7.6.2 Telix Pharmaceuticals Ltd Business Overview
7.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Major Product Offerings
7.6.4 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue in Global Market (2018-2023)
7.6.5 Telix Pharmaceuticals Ltd Key News & Latest Developments
7.7 Lantheus Holdings, Inc
7.7.1 Lantheus Holdings, Inc Company Summary
7.7.2 Lantheus Holdings, Inc Business Overview
7.7.3 Lantheus Holdings, Inc Radioligand Therapy Major Product Offerings
7.7.4 Lantheus Holdings, Inc Radioligand Therapy Revenue in Global Market (2018-2023)
7.7.5 Lantheus Holdings, Inc Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Radioligand Therapy Major Product Offerings
7.8.4 Bayer AG Radioligand Therapy Revenue in Global Market (2018-2023)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Curium Pharma
7.9.1 Curium Pharma Company Summary
7.9.2 Curium Pharma Business Overview
7.9.3 Curium Pharma Radioligand Therapy Major Product Offerings
7.9.4 Curium Pharma Radioligand Therapy Revenue in Global Market (2018-2023)
7.9.5 Curium Pharma Key News & Latest Developments
7.10 Precirix
7.10.1 Precirix Company Summary
7.10.2 Precirix Business Overview
7.10.3 Precirix Radioligand Therapy Major Product Offerings
7.10.4 Precirix Radioligand Therapy Revenue in Global Market (2018-2023)
7.10.5 Precirix Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Radioligand Therapy Market Opportunities & Trends in Global Market
Table 2. Radioligand Therapy Market Drivers in Global Market
Table 3. Radioligand Therapy Market Restraints in Global Market
Table 4. Key Players of Radioligand Therapy in Global Market
Table 5. Top Radioligand Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Radioligand Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Radioligand Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Radioligand Therapy Product Type
Table 9. List of Global Tier 1 Radioligand Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radioligand Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Radioligand Therapy Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Radioligand Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Radioligand Therapy Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Radioligand Therapy Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Radioligand Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Radioligand Therapy Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Radioligand Therapy Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Radioligand Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Radioligand Therapy Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Radioligand Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Radioligand Therapy Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Radioligand Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Radioligand Therapy Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Radioligand Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Radioligand Therapy Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Radioligand Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Radioligand Therapy Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Radioligand Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Radioligand Therapy Revenue, (US$, Mn), 2024-2035
Table 30. Novartis Company Summary
Table 31. Novartis Radioligand Therapy Product Offerings
Table 32. Novartis Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Advanced Accelerator Applications Company Summary
Table 35. Advanced Accelerator Applications Radioligand Therapy Product Offerings
Table 36. Advanced Accelerator Applications Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Advanced Accelerator Applications Key News & Latest Developments
Table 38. Mercy Radiology Company Summary
Table 39. Mercy Radiology Radioligand Therapy Product Offerings
Table 40. Mercy Radiology Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Mercy Radiology Key News & Latest Developments
Table 42. POINT Biopharma Global Inc Company Summary
Table 43. POINT Biopharma Global Inc Radioligand Therapy Product Offerings
Table 44. POINT Biopharma Global Inc Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. POINT Biopharma Global Inc Key News & Latest Developments
Table 46. Fusion Pharma Company Summary
Table 47. Fusion Pharma Radioligand Therapy Product Offerings
Table 48. Fusion Pharma Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Fusion Pharma Key News & Latest Developments
Table 50. Telix Pharmaceuticals Ltd Company Summary
Table 51. Telix Pharmaceuticals Ltd Radioligand Therapy Product Offerings
Table 52. Telix Pharmaceuticals Ltd Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Telix Pharmaceuticals Ltd Key News & Latest Developments
Table 54. Lantheus Holdings, Inc Company Summary
Table 55. Lantheus Holdings, Inc Radioligand Therapy Product Offerings
Table 56. Lantheus Holdings, Inc Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Lantheus Holdings, Inc Key News & Latest Developments
Table 58. Bayer AG Company Summary
Table 59. Bayer AG Radioligand Therapy Product Offerings
Table 60. Bayer AG Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer AG Key News & Latest Developments
Table 62. Curium Pharma Company Summary
Table 63. Curium Pharma Radioligand Therapy Product Offerings
Table 64. Curium Pharma Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Curium Pharma Key News & Latest Developments
Table 66. Precirix Company Summary
Table 67. Precirix Radioligand Therapy Product Offerings
Table 68. Precirix Radioligand Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Precirix Key News & Latest Developments
List of Figures
Figure 1. Radioligand Therapy Segment by Type in 2022
Figure 2. Radioligand Therapy Segment by Application in 2022
Figure 3. Global Radioligand Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Radioligand Therapy Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Radioligand Therapy Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radioligand Therapy Revenue in 2022
Figure 8. By Type - Global Radioligand Therapy Revenue Market Share, 2018-2035
Figure 9. By Application - Global Radioligand Therapy Revenue Market Share, 2018-2035
Figure 10. By Type - Global Radioligand Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Radioligand Therapy Revenue Market Share, 2018-2035
Figure 12. By Application - Global Radioligand Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Radioligand Therapy Revenue Market Share, 2018-2035
Figure 14. By Region - Global Radioligand Therapy Revenue Market Share, 2018-2035
Figure 15. By Country - North America Radioligand Therapy Revenue Market Share, 2018-2035
Figure 16. US Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Radioligand Therapy Revenue Market Share, 2018-2035
Figure 20. Germany Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 21. France Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Radioligand Therapy Revenue Market Share, 2018-2035
Figure 28. China Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 32. India Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Radioligand Therapy Revenue Market Share, 2018-2035
Figure 34. Brazil Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Radioligand Therapy Revenue Market Share, 2018-2035
Figure 37. Turkey Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Radioligand Therapy Revenue, (US$, Mn), 2018-2035
Figure 41. Novartis Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Advanced Accelerator Applications Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mercy Radiology Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. POINT Biopharma Global Inc Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Fusion Pharma Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Telix Pharmaceuticals Ltd Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Lantheus Holdings, Inc Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer AG Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Curium Pharma Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Precirix Radioligand Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
